PAR 7.69% 21.0¢ paradigm biopharmaceuticals limited..

Hi @Mangoman605Looks like we are interpreting 'real deal'...

  1. 692 Posts.
    lightbulb Created with Sketch. 130
    Hi @Mangoman605

    Looks like we are interpreting 'real deal' differently. I was reading it in the context of the OARSI scientific community seeing it as the next big thing in treatment. I think yours is more from an investment and bringing to market view. I agree these are hurdles to overcome.

    I do believe we have added valuable skill sets to the team , including (I hope) more prudent financial management. Although these individuals hold positions of Consultant and Board Member I suspect their input and influence is significant. This placates me somewhat, because I have been bitterly critical of some of managements actions in the past. If management shows a willingness to change and do better, which I think they have with these appointments, I am happy to put that behind me an move on. I believe they are better placed now to manage more responsibly and prudently.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.